Meelia era ends at Covidien as Almeida set to take over company

June 30, 2011 by MassDevice staff

Following two decades at Kendall, Tyco Healthcare and Covidien, Richard Meelia rides off into the sunset at COV.

Covidien CEO Rich Meelia


Richard Meelia, the CEO who led Covidien plc (NYSE:COV) in its various incarnations for more than two decades will hand over the keys to the corner officer to José (Joe) Almeida today without fanfare.

Meelia, 62, was named president & CEO of Covidien in June 2007, after it was spun out of the disintegrating Tyco International. He was elected chairman in October 2008 and has been with the company in its different forms for 20 years.

Meelia was also president at Kendall Healthcare Products Co., which was spun into Tyco Healthcare and then Covidien, growing the business from $600 million to more than $10.4 billion in 2010.

Meelia will stay on as non-executive chairman of Covidien's board for a transition period of up to a year after his retirement, according to a press release

Listen to incoming Covidien CEO Joe Almeida discuss his new position at the MassDevice Big 100 Regional Roundtable on July 11

In a statement sent to MassDevice Meelia said he had every confidence in his successor.

"Joe Almeida is a great leader who has proven his mettle over many years, most recently in his outstanding direction of our Medical Devices segment," he said. "As I prepare to transition my responsibilities to Joe, I have every confidence that, backed by our superb global workforce, he will lead our Company on to even better performance and greater success in the years to come."